Bexitrol F Inhalation Capsule 50 mcg+250 mcg is a fixed-dose combination inhalation therapy containing Salmeterol, a long-acting beta-2 adrenergic agonist, and Fluticasone Propionate, a potent inhaled corticosteroid. This formulation is designed for the regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients who require both sustained bronchodilation and effective control of airway inflammation.

The inhalation capsules are intended to be used with a compatible dry powder inhaler device. By delivering medication directly to the lungs, Bexitrol F ensures targeted action, faster onset of effect, and reduced systemic side effects compared to oral therapies. It is not indicated for the relief of acute bronchospasm and should be used consistently as prescribed for optimal disease control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Long-acting beta-2 agonist (LABA) + Inhaled corticosteroid (ICS)

Indications

Bexitrol F Inhalation Capsule 50 mcg+250 mcg is indicated for:

• Maintenance treatment of moderate persistent bronchial asthma not adequately controlled with inhaled corticosteroids alone

• Long-term management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

• Prevention of asthma symptoms such as wheezing, shortness of breath, chest tightness, and night-time awakenings

This strength is suitable for patients who require combination therapy with a moderate dose of inhaled corticosteroid for improved symptom control.

Pharmacology

Salmeterol acts selectively on beta-2 adrenergic receptors in bronchial smooth muscle, producing prolonged relaxation and bronchodilation lasting up to 12 hours. This helps maintain open airways, reduces bronchospasm, and improves airflow throughout the day and night.

Fluticasone Propionate is a highly effective inhaled corticosteroid that suppresses airway inflammation by inhibiting inflammatory mediators, reducing mucosal edema, and decreasing inflammatory cell infiltration. Regular use lowers airway hyper-responsiveness and reduces the frequency and severity of asthma exacerbations.

The combined action of Salmeterol and Fluticasone Propionate provides synergistic benefits, resulting in better lung function and long-term disease control.

Dosage and Administration

Bexitrol F Inhalation Capsule is for inhalation use only.

• The usual recommended dose is one inhalation capsule twice daily or as directed by a physician

• Capsules must not be swallowed and should only be used with an appropriate inhaler device

• Patients should rinse their mouth with water after inhalation and spit it out to reduce the risk of oral fungal infections

Regular and consistent use is essential for maximum therapeutic benefit.

Contraindications

Bexitrol F Inhalation Capsule is contraindicated in:

• Patients with known hypersensitivity to Salmeterol, Fluticasone Propionate, or any component of the formulation

• Acute asthma attacks or status asthmaticus requiring rapid-acting bronchodilators

Side Effects

Possible side effects may include:

• Throat irritation or hoarseness

• Headache

• Cough

• Oral candidiasis

• Tremor or palpitations (uncommon)

Most side effects are mild and can be minimized with proper inhaler technique and mouth rinsing.

Precautions and Warnings

• Not intended for the relief of acute bronchospasm

• Use with caution in patients with cardiovascular disorders, diabetes mellitus, or thyroid disease

• Avoid abrupt discontinuation without medical advice

• Long-term use requires periodic medical monitoring

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Pregnancy and Lactation

Bexitrol F Inhalation Capsule should be used during pregnancy and lactation only if the potential benefit justifies the potential risk, and under medical supervision.

Storage Conditions

Store below 30°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Conclusion

Bexitrol F Inhalation Capsule 50 mcg+250 mcg is an effective and well-balanced maintenance therapy for asthma and COPD. By combining prolonged bronchodilation with reliable anti-inflammatory action, it helps achieve sustained symptom control, reduces exacerbations, and improves overall respiratory health.